Steven Pearlstein
assesses the CVS / Caremark merger in the Washington Post this morning. Analysts
predict that the merger will survive government antitrust review. Both companies
announced strong third quarter earnings yesterday. The merger is expected to close next year.
No comments:
Post a Comment